AstraZeneca is seeking a Head of Radioconjugates Strategy & Delivery within their Oncology Targeted Discovery unit to oversee the development and commercialization of radioconjugate therapies. The ideal candidate will possess extensive experience in drug development, especially with radioconjugates, and will be responsible for orchestrating cross-functional collaboration and strategy execution.
Base: $246,069.60 - $369,104.40; Bonus/Equity: short-term incentive bonus opportunity; equity-based long-term incentive program; Benefits: qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage
Must-have
Nice-to-have
Not specified
Discover valuable connections who might provide insights and referrals.
Get 3x more responses when you reach out individually.